Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2093-985X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Deep learning prediction of non-perfused volume without contrast agents during prostate ablation therapy ; day:8 ; month:11 ; year:2022 ; pages:1-10
Biomedical engineering letters ; (8.11.2022), 1-10
- Creator
-
Wright, Cameron
Mäkelä, Pietari
Bigot, Alexandre
Anttinen, Mikael
Boström, Peter J.
Blanco Sequeiros, Roberto
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13534-022-00250-y
- URN
-
urn:nbn:de:101:1-2023012209502726078971
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wright, Cameron
- Mäkelä, Pietari
- Bigot, Alexandre
- Anttinen, Mikael
- Boström, Peter J.
- Blanco Sequeiros, Roberto
- SpringerLink (Online service)
Other Objects (12)
Biogenic Imaging Contrast Agents
Contrast agents and the kidney
Photofunctional contrast agents for multiscale-multimodal imaging
Glucose-installed, SPIO-loaded PEG-b-PCL micelles as MR contrast agents to target prostate cancer cells
Ablation energies for focal treatment of prostate cancer
Investigations of signal-enhanced magnetic resonance contrast agents
Multiwalled carbon nanotube hybrids as MRI contrast agents
Correction to: Magnetic Nanoparticles as MRI Contrast Agents
Theranostics and contrast agents for magnetic resonance imaging
Novel Contrast Agents in Photon-Counting Computed Tomography
Contrast-medium administration for prostate MRI: yes! Contrast-medium administration can be abandoned
Dynamic contrast enhanced MRI atlas of prostate cancer
Biogenic Imaging Contrast Agents
Contrast agents and the kidney
Photofunctional contrast agents for multiscale-multimodal imaging
Glucose-installed, SPIO-loaded PEG-b-PCL micelles as MR contrast agents to target prostate cancer cells
Ablation energies for focal treatment of prostate cancer
Investigations of signal-enhanced magnetic resonance contrast agents
Multiwalled carbon nanotube hybrids as MRI contrast agents
Correction to: Magnetic Nanoparticles as MRI Contrast Agents
Theranostics and contrast agents for magnetic resonance imaging
Novel Contrast Agents in Photon-Counting Computed Tomography
Contrast-medium administration for prostate MRI: yes! Contrast-medium administration can be abandoned
Dynamic contrast enhanced MRI atlas of prostate cancer
Biogenic Imaging Contrast Agents
Contrast agents and the kidney
Photofunctional contrast agents for multiscale-multimodal imaging
Glucose-installed, SPIO-loaded PEG-b-PCL micelles as MR contrast agents to target prostate cancer cells
Ablation energies for focal treatment of prostate cancer
Investigations of signal-enhanced magnetic resonance contrast agents
Multiwalled carbon nanotube hybrids as MRI contrast agents
Correction to: Magnetic Nanoparticles as MRI Contrast Agents
Theranostics and contrast agents for magnetic resonance imaging
Novel Contrast Agents in Photon-Counting Computed Tomography
Contrast-medium administration for prostate MRI: yes! Contrast-medium administration can be abandoned